Jones Financial Companies
NVCR icon

Jones Financial Companies’s NovoCure NVCR Stock Holding History

Jones Financial Companies’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.51K Sell
320
-900
-74% -$11.2K ﹤0.01% 3973
2025
Q4 		$15.8K Sell
1,220
-390
-24% -$5.01K ﹤0.01% 3030
2025
Q3 		$20.8K Buy
1,610
+65
+4% +$868 ﹤0.01% 2783
2025
Q2 		$27.8K Sell
1,545
-36
-2% -$627 ﹤0.01% 2458
2025
Q1 		$29.8K Buy
1,581
+1,140
+259% +$25.9K ﹤0.01% 2276
2024
Q4 		$13.1K Buy
441
+438
+14,600% +$9.27K ﹤0.01% 2415
2024
Q3 		$47 Buy
+3
New +$54 ﹤0.01% 2993

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Jones Financial Companies's NVCR Position: Q1 2026 in Review

Jones Financial Companies reduced its NovoCure (NVCR) stake by 74% in Q1 2026, selling an estimated $11.2K and leaving 320 shares worth $3.51K. The position accounts for ﹤0.01% of the portfolio, ranked #3973.

Jones Financial Companies first reported a position in NVCR in Q3 2024 and has held it in 7 quarters since. The position peaked at $29.8K in Q1 2025. 223 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Jones Financial Companies held 320 shares of NovoCure worth $3.51K as of Q1 2026.
  • Jones Financial Companies sold 900 NovoCure shares in Q1 2026, an estimated $11.2K.
  • NovoCure made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3973 holding.
  • Jones Financial Companies first reported a position in NovoCure in Q3 2024 and has held it in 7 quarters since.
  • Jones Financial Companies's NovoCure position peaked at $29.8K in Q1 2025.
  • 223 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.